The growth potential of the healthcare industry is very positive. SHL, with its vast knowledge of the market, strong retail and distribution network and efficient working capital management, is all set to capitalize on this fact. Changes in demographics and consumer inclinations support the statement that SHL is well set to increase its role in the healthcare industry. Sri Lanka has the fastest ageing population in South Asia, and those above 60 are estimated to constitute over 1/5th of the population by 2030. An ageing population and increased longevity will create new demand for therapeutic geriatric products. Its international healthcare partners ensure that SHL is always well abreast of the latest innovations in medical technology and research and will continue to introduce appropriate and valuable new products to the market.